Skip to content

The clinical trial of transcranial photobiomodulation on improving cognition functions of patients with adult ADHD and depression disorder

The clinical trial of transcranial photobiomodulation on improving cognition functions of patients with adult ADHD and depression disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083500
Enrollment
Unknown
Registered
2024-04-26
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adults with ADHD and/or major depressive disorders

Interventions

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) 18-45 years of age; 2) Diagnosed by an attending psychiatrist or higher who meets the DSM-5 diagnostic criteria for ADHD (current) and/or MDD (current or past) in adults; (3) The patient with MDD has a DSM-5 diagnosis of "psychomotor retardation" or "reduced ability to think or concentrate or indecisiveness"; (4) HAMD-24 score = 20; 5) Unmedicated; the dose of medication has not been adjusted in the last 4 weeks and has remained unchanged during the study.

Exclusion criteria

Exclusion criteria: 1) Suffering from a mental disorder other than ADHD, MDD, or anxiety spectrum disorder; 2) Have neurological disorders such as history of epilepsy, history of traumatic brain injury, or serious physical illness; 3) Being pregnant or breastfeeding; 4) Severe suicidal ideation (score =3 on the suicide item of the HAM-D) and recent presence of self-injurious behavior; 5) Those with an intelligence level below the normal range, i.e., a total IQ score of less than 90 on the Wechsler Intelligence Test; 6) A frontal skin condition that may impede light penetration, such as tattoos or birthmarks; 7) Receiving photosensitizing medication within 14 days; 8) Have implants in the head, such as endovascular stent placement, to prevent possible dislocation associated with vasodilation; 9) Undergoing psychotherapy or other physical therapy methods.

Design outcomes

Primary

MeasureTime frame
Accuracy and response time for N-back tasks;

Secondary

MeasureTime frame
CPT-IP signal detection index;24-Item Hamilton Depression Scale (HAMD-24) Score;

Countries

China

Contacts

Public ContactQian Qiujin

Peking University Sixth Hospital

qianqiujin@bjmu.edu.cn+86 10 6272 3701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026